In-silico screening of naturally derived phytochemicals against SARS-CoV Main protease

Abstract

Coronavirus disease 2019 (COVID-19) is a rapidly growing pandemic that requires urgent therapeutic intervention. Finding potential anti COVID-19 drugs aside from approved vaccines is progressively going on. The chemically diverse natural products represent valuable sources for drug leads. In this study, we aimed to find out safe and effective COVID-19 protease inhibitors from a library of natural products which share the main nucleus/skeleton of FDA-approved drugs that were employed in COVID-19 treatment guidelines or repurposed by previous studies. Our library was subjected to virtual screening against SARS-CoV Main protease (Mpro) using Molecular Operating Environment (MOE) software. Twenty-two out of those natural candidates showed higher binding scores compared to their analogues. We repurpose these natural products including alkaloids, glucosinolates, and phenolics as potential platforms for the development of anti-SARS-CoV-2 therapeutics. This study paves the way towards discovering a lead used in the treatment of COVID-19 from natural sources and introduces phytomedicines with dual therapeutic effects against COVID-19 besides their original pharmacological effects. We recommend further in vitro evaluation of their anti-COVID-19 activity and future clinical studies.

Theaflavin Ameliorates Streptococcus suis-Induced Infection In Vitro and In Vivo

“…Molecular docking of the interaction mode between TF1 and Sly was conducted by the molecular operating environment (MOE) [ 46 , 47 ]. The chemical structure of TF1 was downloaded from PubChem, and the three-dimensional (3D) structure of Sly was obtained from the Protein Database (PDB).…”

The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine

“…According to the World Health Organization (WHO), more than 550 million cases were confirmed globally, with more than 6.3 million deaths reported so far. There were tremendous efforts for the early detection of COVID-19, the identification of severity biomarkers [ 4 ], and the design of effective therapeutics against COVID-19 employing different approaches, such as the in silico screening of previously approved therapeutics and phytochemicals or the rational design of novel drugs against the crucial enzymes of the SARS-CoV-2 virus [ 5 , 6 , 7 , 8 , 9 , 10 ]. Effective vaccines against COVID-19 were designed and achieved remarkable feedback on COVID-19 transmission, hospitalization, and mortality [ 11 ].…”

Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics

“…Since the outbreak of COVID-19, several approaches were proposed for finding potential therapeutics [ 11 , 12 , 13 , 14 , 15 , 16 ], until the development of effective anti-COVID-19 vaccines [ 17 ].…”